Pyruvate dehydrogenase complex regulation and lipoic acid

Lipoic Acid: Energy Production, Antioxidant Activity and Health Effects

Volumn , Issue , 2008, Pages 149-165

  Korotchkina, Lioubov G ^a   Patel, Mulchand S ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 71549155062     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (67)

1. Konrad, T. et al. Alpha-lipoic acid treatment decreases serum lactate and pyruvate concentrations and improves glucose effectiveness in lean and obese patients with type 2 diabetes, Diabetes Care 22, 280, 1999.
2. Jacob, S. et al. Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: A placebo-controlled pilot trial, Free Radic. Biol. Med. 27, 309, 1999.
3. Moini, H., Packer, L., and Saris, N.E. Antioxidant and prooxidant activities of alphalipoic acid and dihydrolipoic acid, Toxicol. Appl. Pharmacol. 182, 84, 2002.
4. Konrad, D. et al. The antihyperglycemic drug alpha-lipoic acid stimulates glucose uptake via both GLUT4 translocation and GLUT4 activation: Potential role of p38 mitogen-activated protein kinase in GLUT4 activation, Diabetes 50, 1464, 2001.
5. Moini, H. et al. R-alpha-lipoic acid action on cell redox status, the insulin receptor, and glucose uptake in 3T3-L1 adipocytes, Arch. Biochem. Biophys. 397, 384, 2002.
6. Korotchkina, L.G., Sidhu, S., and Patel, M.S. R-lipoic acid inhibits mammalian pyruvate dehydrogenase kinase, Free Radic Res. 38, 1083, 2004.
7. Korotchkina, L.G. et al. Protection by thiols of the mitochondrial complexes from 4-hydroxy-2-nonenal, Free Radic. Biol. Med. 30, 992, 2001.
8. Walgren, J.L. et al. Effect of R(+)alpha-lipoic acid on pyruvate metabolism and fatty acid oxidation in rat hepatocytes, Metabolism: Clin. & Exper. 53, 16, 2004.
9. Packer, L., Kraemer, K., and Rimbach, G. Molecular aspects of lipoic acid in the prevention of diabetes complications, Nutrition 17, 888, 2001.
10. Patel, M.S. and Korotchkina, L.G. The biochemistry of the pyruvate dehydrogenase complex, Biochem. Mol. Biol. Educ. 31, 5, 2003.
11. Bustamante, J. et al. Alpha-lipoic acid in liver metabolism and disease, Free Radic. Biol. Med. 24, 1023, 1998.
12. Hiromasa, Y. et al. Organization of the cores of the mammalian pyruvate dehydrogenase complex formed by E2 and E2 plus the E3-binding protein and their capacities to bind the E1 and E3 components, J. Biol. Chem. 279, 6921, 2004.
13. Harris, R.A. et al. Dihydrolipoamide dehydrogenase-binding protein of the human pyruvate dehydrogenase complex. DNA-derived amino acid sequence, expression, and reconstitution of the pyruvate dehydrogenase complex, J. Biol. Chem. 272, 19746, 1997.
14. Roche, T.E. et al. Distinct regulatory properties of pyruvate dehydrogenase kinase and phosphatase isoforms, Progr. Nucl. Acid Res. Molec. Biol. 70, 33, 2001.
15. Ciszak, E.M. et al. Structural basis for flip-flop action of thiamin pyrophosphatedependent enzymes revealed by human pyruvate dehydrogenase, J. Biol. Chem. 278, 21240, 2003.
16. Howard, M.J. et al. Three-dimensional structure of the major autoantigen in primary biliary cirrhosis, Gastroenterology 115, 139, 1998.
17. Brautigam, C.A. et al. Crystal structure of human dihydrolipoamide dehydrogenase: NAD+/NADH binding and the structural basis of disease-causing mutations, J. Mol. Biol. 350, 543, 2005.
18. Ciszak, E.M. et al. How dihydrolipoamide dehydrogenase-binding protein binds dihydrolipoamide dehydrogenase in human pyruvate dehydrogenase complex, J. Biol. Chem. 281, 648, 2006.
19. Steussy, C.N. et al. Structure of pyruvate dehydrogenase kinase. Novel folding pattern for a serine protein kinase, J. Biol. Chem. 276, 37443, 2001.
20. Knoechel, T.R. et al. Regulatory roles of the N-terminal domain based on crystal structures of human pyruvate dehydrogenase kinase 2 containing physiological and synthetic ligands, Biochemistry 45, 402, 2006.
21. Kato, M. et al. Crystal structure of pyruvate dehydrogenase kinase 3 bound to lipoyl domain 2 of human pyruvate dehydrogenase complex, EMBO J. 24, 1763, 2005.
22. Mattevi, A. et al. Atomic structure of the cubic core of the pyruvate dehydrogenase multienzyme complex, Science 255, 1544, 1992.
23. Izard, T. et al. Principles of quasi-equivalence and Euclidean geometry govern the assembly of cubic and dodecahedral cores of pyruvate dehydrogenase complexes, Proc. Natl. Acad. Sci. U.S. A. 96, 1240, 1999.
24. Zhou, Z.H. et al. The remarkable structural and functional organization of the eukaryotic pyruvate dehydrogenase complexes, Proc. Natl. Acad. Sci. U.S.A. 98, 14802, 2001.
25. Nemeria, N.S. et al. Acetylphosphinate is the most potent mechanism-based substrate inhibitor of both the human and E. coli pyruvate dehydrogenase components of the pyruvate dehydrogenase complex, Bioorg. Chem. 34, 362, 2006.
26. Seifert, F. et al. Direct kinetic evidence for half-of-the-sites reactivity in the E1 component of the human pyruvate dehydrogenase multienzyme complex through alternating sites cofactor activation, Biochemistry 45, 12775, 2006.
27. Nemeria, N. et al. The 1',4'-iminopyrimidine tautomer of thiamin diphosphate is poised for catalysis in asymmetric active centers on enzymes, Proc. Natl. Acad. Sci. U.S.A. 104, 78, 2007.
28. Sugden, P.H. and Randle, P.J. Regulation of pig heart pyruvate dehydrogenase by phosphorylation. Studies on the subunit and phosphorylation stoichiometries, Biochem. J. 173, 659, 1978.
29. Korotchkina, L.G. and Patel, M.S. Mutagenesis studies of the phosphorylation sites of recombinant human pyruvate dehydrogenase. Site-specific regulation, J. Biol. Chem. 270, 14297, 1995.
30. Patel, M.S. and Korotchkina, L.G. Regulation of the pyruvate dehydrogenase complex, Biochem. Soc. Trans. 34, 217, 2006.
31. Yeaman, S.J. et al. Sites of phosphorylation on pyruvate dehydrogenase from bovine kidney and heart, Biochemistry 17, 2364, 1978.
32. Dahl, H.H. et al. The human pyruvate dehydrogenase complex. Isolation of cDNA clones for the E1 alpha subunit, sequence analysis, and characterization of the mRNA, J. Biol. Chem., 262, 7398, 1987.
33. Korotchkina, L.G. and Patel, M.S. Probing the mechanism of inactivation of human pyruvate dehydrogenase by phosphorylation of three sites, J. Biol. Chem. 276, 5731, 2001.
34. Bowker-Kinley, M.M. et al. Evidence for existence of tissue-specific regulation of the mammalian pyruvate dehydrogenase complex, Biochem. J. 329, 191, 1998.
35. Rowles, J. et al. Cloning and characterization of PDK4 on 7q21.3 encoding a fourth pyruvate dehydrogenase kinase isoenzyme in human, J. Biol. Chem. 271, 22376, 1996.
36. Korotchkina, L.G. and Patel, M.S. Site specificity of four pyruvate dehydrogenase kinase isoenzymes toward the three phosphorylation sites of human pyruvate dehydrogenase, J. Biol. Chem. 276, 37223, 2001.
37. Kolobova, E. et al. Regulation of pyruvate dehydrogenase activity through phosphorylation at multiple sites, Biochem. J. 358, 69, 2001.
38. Huang, B. et al. Isoenzymes of pyruvate dehydrogenase phosphatase. DNA-derived amino acid sequences, expression and regulation, J. Biol. Chem. 273, 17680, 1998.
39. Huang, B. et al. Starvation and diabetes reduce the amount of pyruvate dehydrogenase phosphatase in rat heart and kidney, Diabetes 52, 1371, 2003.
40. Karpova, T. et al. Characterization of the isozymes of pyruvate dehydrogenase phosphatase: Implications for the regulation of pyruvate dehydrogenase activity, Biochim. Biophys. Acta 1652, 126, 2003.
41. Harris, R.A., Huang, B., and Wu, P. Control of pyruvate dehydrogenase kinase gene expression, Adv. Enzyme Regul. 41, 269, 2001.
42. Wu, P. et al. Starvation and diabetes increase the amount of pyruvate dehydrogenase kinase isoenzyme 4 in rat heart, Biochem. J. 329, 197, 1998.
43. Wu, P. et al. Starvation increases the amount of pyruvate dehydrogenase kinase in several mammalian tissues, Arch. Biochem. Biophys. 381, 1, 2000.
44. Sugden, M.C. and Holness, M.J. Therapeutic potential of the mammalian pyruvate dehydrogenase kinases in the prevention of hyperglycaemia, Curr. Drug Targets- Imm. Endocr. Met. Dis. 2, 151, 2002.
45. Bajotto, G. et al. Downregulation of the skeletal muscle pyruvate dehydrogenase complex in the Otsuka Long-Evans Tokushima fatty rat both before and after the onset of diabetes mellitus, Life Sci. 75, 2117, 2004.
46. Kwon, H.S. and Harris, R.A. Mechanisms responsible for regulation of pyruvate dehydrogenase kinase 4 gene expression, Adv. Enzyme Regul. 44, 109, 2004.
47. Caruso, M. et al. Activation and mitochondrial translocation of protein kinase CS are necessary for insulin stimulation of pyruvate dehydrogenase complex activity in muscle and liver cells, J. Biol. Chem. 276, 45088, 2001.
48. Johnson, S.A. and Denton, R.M. Insulin stimulation of pyruvate dehydrogenase in adipocytes involves two distinct signalling pathways, Biochem. J. 369, 351, 2003.
49. Tuganova, A., Boulatnikov, I., and Popov, K.M. Interaction between the individual isoenzymes of pyruvate dehydrogenase kinase and the inner lipoyl-bearing domain of transacetylase component of pyruvate dehydrogenase complex, Biochem. J. 366, 129, 2002.
50. Roche, T.E. et al. Essential roles of lipoyl domains in the activated function and control of pyruvate dehydrogenase kinases and phosphatase isoform 1, Eur. J. Biochem. 270, 1050, 2003.
51. Tuganova, A. and Popov, K.M. Role of protein-protein interactions in the regulation of pyruvate dehydrogenase kinase activity, Biochem. J. 387, 147, 2005.
52. Baker, J.C. et al. Marked differences between two isoforms of human pyruvate dehydrogenase kinase, J. Biol. Chem. 275, 15773, 2000.
53. Hiromasa, Y. and Roche, T.E. Facilitated interaction between the pyruvate dehydrogenase kinase isoform 2 and the dihydrolipoyl acetyltransferase, J. Biol. Chem. 278, 33681, 2003.
54. Bao, H. et al. Pyruvate dehydrogenase kinase isoform 2 activity stimulated by speeding up the rate of dissociation of ADP, Biochemistry 43, 13442, 2004.
55. Hiromasa, Y., Hu, L., and Roche, T.E. Ligand-induced effects on pyruvate dehydrogenase kinase isoform 2, J. Biol. Chem. 281, 12568, 2006.
56. Turkan, A., Hiromasa, Y., and Roche, T.E. Formation of a complex of the catalytic subunit of pyruvate dehydrogenase phosphatase isoform 1 (PDP1c) and the L2 domain forms a Ca2th binding site and captures PDP1c as a monomer, Biochemistry 43, 15073, 2004.
57. Cho, K.J. et al. Alpha-lipoic acid decreases thiol reactivity of the insulin receptor and protein tyrosine phosphatase 1B in 3T3-L1 adipocytes, Biochem. Pharmacol. 66, 849, 2003.
58. Diesel, B. et al. a-Lipoic acid as a directly binding activator of the insulin receptor: Protection from hepatocyte apoptosis, Biochemistry 46, 2146, 2007.
59. Maitra, I. et al. Alpha-lipoic acid prevents buthionine sulfoximine-induced cataract formation in newborn rats, Free Radic. Biol. Med. 18, 823, 1995.
60. Kunt, T. et al. Alpha-lipoic acid reduces expression of vascular cell adhesion molecule-1 and endothelial adhesion of human monocytes after stimulation with advanced glycation end products, Clin. Sci. (Lond.) 96, 75, 1999.
61. Haak, E. et al. Effects of alpha-lipoic acid on microcirculation in patients with peripheral diabetic neuropathy, Exp. Clin. Endocrinol. Diabetes 108, 168, 2000.
62. Sheline, C.T. and Wei, L. Free radical-mediated neurotoxicity may be caused by inhibition of mitochondrial dehydrogenases in vitro and in vivo, Neuroscience 140, 235, 2006.
63. Tabatabaie, T., Potts, J.D., and Floyd, R.A. Reactive oxygen species-mediated inactivation of pyruvate dehydrogenase, Arch. Biochem. Biophys. 336, 290, 1996.
64. Hong, Y.S. et al. The inhibitory effects of lipoic compounds on mammalian pyruvate dehydrogenase complex and its catalytic components, Free Radic. Biol. Med. 26, 685, 1999.
65. Humphries, K.M., Yoo, Y., and Szweda, L.I. Inhibition of NADH-linked mitochondrial respiration by 4-hydroxy-2-nonenal, Biochemistry 37, 552, 1998.
66. Gandhi, V.M. et al. Lipoic acid and diabetes II: Mode of action of lipoic acid, J. Biosci. 9, 117, 1985.
67. Bao, H. et al. Pyruvate dehydrogenase kinase isoform 2 activity limited and further inhibited by slowing down the rate of dissociation of ADP, Biochemistry 43, 13432, 2004.